

Obstructive Sleep Apnea (OSA) is a chronic condition that significantly impacts quality of life and increases the risk of cardiovascular disease. The Neuroscience Center at Bangkok Hospital Pattaya has developed a comprehensive patient care system to deliver meaningful long-term outcomes.
We uphold international standards to ensure the most accurate diagnosis for every patient:
For moderate to severe OSA patients treated with Continuous Positive Airway Pressure (CPAP), our outcomes exceed international benchmarks:
exceeding the 60% target
After 3 months of follow-up, patients reported positive changes across multiple areas:
Bangkok Hospital Pattaya’s OSA care outcomes demonstrate exceptional quality — particularly in CPAP adherence, disease control, and quality of life improvements — surpassing international trends. This reflects our practical application of Value-Based Care, delivering health, safety, and quality of life for every patient while reducing the risk of complications and long-term healthcare costs.
We use Polysomnography (PSG) Type 1 — the highest international standard for sleep disorder diagnosis — enabling physicians to accurately assess the severity of each patient’s condition.
Absolutely. Our data shows that 90% of patients achieved normal AHI levels after CPAP treatment, and 100% of patients maintained consistent device usage throughout their treatment.
Significantly. Our clinical outcome data shows that 85% of patients experienced a notable improvement in blood pressure within 3 months of appropriate treatment.
After 3 months of follow-up, patients reported an average 76% reduction in daytime sleepiness — exceeding international benchmarks — allowing them to return to work and drive more safely.